Veterinary Medicine Information website

Biocan DHPPi+LR Liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań

Authorised
  • Canine distemper virus, strain CDVU 39, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine parvovirus, strain OP-I/81, Live
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
  • Algeldrate
Download as PDF

Product identification

Medicine name:
Biocan DHPPi+LR Liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań
Active substance:
  • Canine distemper virus, strain CDVU 39, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine parvovirus, strain OP-I/81, Live
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
  • Algeldrate
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain CDVU 39, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine parvovirus, strain OP-I/81, Live
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
  • Algeldrate
    2.00
    milligram(s)
    /
    1.00
    milligram(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Grabikowski-Grabikowska Przedsiebiorstwo Produkcyjno-Handlowo-Uslugowe Inex Sp. j.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2011
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download